Meet the OBR Editorial Board

Editor’s Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards’s insights will bring great value to the oncology community.

View all Editorial Board Member Comment

Browse Editors by Section

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center

Comments

Scientists Identify Unique Genomic Features in Testicular Cancer

quotesThese findings are an example of the power of genomic sequencing and bioinformatic analysis - with a…quotes

member-photo

Howard S. Hochster, MD

Associate Cancer Center Director, Yale Cancer Center Professor of Medicine, Yale School of Medicine New Haven, CT 06520

Comments

U.S. Supreme Court Agrees To Hear Dispute Over Biologic Drug Sales

quotesThe Supreme Court ruling is important in the coming era of biosimilars. This is an area where the S…quotes

member-photo

Richard Goldberg, MD

Professor and Physician-in-Chief of the Ohios State University James Cancer Hospital and Solove Research Institute

Comments

Genetic Differences Distinguish Stomach Cancers, Treatment Response

quotesThe availability of a molecular signature that differentiates intestinal type from diffuse type gast…quotes

member-photo

H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA; CEO, Global Resource for Advancing Cancer Education (GRACE)

Comments

Big Pharma Faces Costly Setback In Cancer Fight

quotesWhat is most remarkable is how many successes we've had with immunotherapies across a wide range of …quotes

member-photo

Winston Wong, PharmD

President, W-Squared Group

Comments

Payers Weigh the Implications of Multigene Testing Coverage in New UCSF Study

quotesWhile payers may not be in agreement for covering these multigene panels for assessing hereditary ri…quotes

member-photo

Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst

Comments

U.S. Food and Drug Administration Approves POMALYST® (pomalidomide) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

quotesI am excited to be joining the editorial board on OBR; I have been a fan of the publication since it…quotes

member-photo

Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One

No comments to show!!

member-photo

Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology Department of Medicine,Cedars-Sinai Medical Center Associate Director for Academic Program Development Samuel Oschin Comprehensive Cancer Institute Professor of Medicine and Urology, Emeritus David Geffen School of Medicine at UCLA

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Joseph Bailes, MD

National Health Policy Expert

Comments

FDA Plans Oversight of Some Mobile Medical Apps

quotesRegulatory agencies are concerned about the proliferation of mobile medical applications. As more h…quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

From Twitter To Treatment Guidelines, Industry Influence Permeates Medicine

quotesSupport received by organizations from various stakeholders for educational programs and other activ…quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology

Comments

Phase III Trial of Anticancer Agent Lenvima As First-Line Treatment For Unresectable Hepatocellular Carcinoma Meets Primary Endpoint

quotesA very welcome advance in HCC therapy with lenvatinib dosing which is lower than the initial recomme…quotes

member-photo

Jeff Patton, M.D.

CEO Tennessee Oncology

Comments

Genentech’s Shocking $2 Billion 340B Revelation

quotesGood for Genentech! The abuse of this program needs to end ASAP. I agree with the author and hope …quotes

member-photo

Thomas Marsland, MD

Vice President Integrated Community Oncology Network Former Community Representative ASCO Board of Directors

Comments

Non-Profit Drug Development Could Cut Cost of Cancer Medicines

quotesThere is no free lunch (unfortunately). I would like to comment on actually two reports in today's…quotes

member-photo

William Harwin MD

Florida Cancer Specialists President and Managing Partner

Comments

Memorial Sloan Kettering to Offer DigniCap® Scalp Cooling Device in New York Metro Area Locations

quotesAt Florida Cancer Specialists we have been using DigniCap for several months at 3 of our site and it…quotes

member-photo

Howard Sandler, MD, MS, FASTRO

Professor and Chair, Department of Radiation Oncology

Comments

Doctor-Owned Centers Spark Criticism, Scrutiny

quotesThis article in the Washington Post highlights an area of interest as we enter an era of health care…quotes